Achieve Life Sciences gets a CRL; UPS invests $48M in healthcare logistics

Achieve Life Sciences gets FDA CRL for cytisinicline; UPS puts $48M into cold-chain logistics; AdvanCell is establishing a US headquarters and Jubilant recievs FDA warning letter. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and…

Anna Brown · 2026-06-25

Plus, news about AdvanCell and Jubilant. 🔴 FDA rejects drug for nicotine dependence: Achieve Life Sciences received a complete response letter for cytisinicline due to issues at a third-party manufacturing facility ...

Source: Endpoints News